Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Historical Holders from Q2 2019 to Q4 2024

Symbol
MIST on Nasdaq
CUSIP
59935V107
Type / Class
Equity / Common Shares, no par value per share
Shares outstanding
56.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
24.5M
Holdings value
$57.9M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
46
Number of buys
21
Number of sells
-21
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.99% $4.96M 5.64M RTW Investments, LP Dec 31, 2024

Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 24.5M $57.9M -$9.79M $2.36 46
2024 Q3 28.7M $43.6M -$2.29M $1.52 41
2024 Q2 30.2M $39.9M -$1.77M $1.32 40
2024 Q1 31.1M $55.6M +$23.7M $1.79 40
2023 Q4 17.8M $29.7M -$3.46M $1.67 37
2023 Q3 19.4M $60M -$3.31M $3.10 37
2023 Q2 20.5M $58.3M -$3.17M $2.85 46
2023 Q1 21.5M $84.7M -$10.2M $3.94 47
2022 Q4 23.7M $93.7M -$29.5M $3.96 53
2022 Q3 20.4M $187M +$9.68M $9.19 42
2022 Q2 20.8M $127M -$2.81M $6.14 28
2022 Q1 20.2M $130M +$5.07M $6.42 26
2021 Q4 19.4M $127M +$2M $6.55 25
2021 Q3 19.9M $114M -$1.09M $5.71 29
2021 Q2 20.1M $111M -$855K $5.50 30
2021 Q1 20.3M $117M -$1.99M $5.79 31
2020 Q4 20.6M $138M +$34M $6.70 32
2020 Q3 15.5M $113M +$42.8M $7.32 28
2020 Q2 9.74M $36.8M +$2.94M $3.78 22
2020 Q1 9.23M $17M -$32.7M $1.84 15
2019 Q4 14.4M $230M +$20.2M $16.01 23
2019 Q3 13.1M $240M -$2.84M $18.65 22
2019 Q2 13.1M $350M +$350M $27.15 23